These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34360568)

  • 21. Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.
    Kallaur AP; Lopes J; Oliveira SR; Simão AN; Reiche EM; de Almeida ER; Morimoto HK; de Pereira WL; Alfieri DF; Borelli SD; Kaimen-Maciel DR; Maes M
    Mol Neurobiol; 2016 Oct; 53(8):5191-202. PubMed ID: 26399644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.
    Lukas C; Knol DL; Sombekke MH; Bellenberg B; Hahn HK; Popescu V; Weier K; Radue EW; Gass A; Kappos L; Naegelin Y; Uitdehaag BM; Geurts JJ; Barkhof F; Vrenken H
    J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):410-8. PubMed ID: 24973341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalamic atrophy correlates with dysfunctional impulsivity in multiple sclerosis.
    Joly H; Capet N; Mondot L; Cohen M; Suply C; Bresch S; Lebrun-Frenay C
    Mult Scler Relat Disord; 2020 Sep; 44():102374. PubMed ID: 32652509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
    Ratzer R; Søndergaard HB; Christensen JR; Börnsen L; Borup R; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1841-8. PubMed ID: 24085340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.
    Choi IY; Lee P; Adany P; Hughes AJ; Belliston S; Denney DR; Lynch SG
    Mult Scler; 2018 Jul; 24(8):1029-1038. PubMed ID: 28569645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
    Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
    Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological differences between classical phenothypes of multiple sclerosis.
    Iwanowski P; Losy J
    J Neurol Sci; 2015 Feb; 349(1-2):10-4. PubMed ID: 25586536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene Regulatory Networks in Peripheral Mononuclear Cells Reveals Critical Regulatory Modules and Regulators of Multiple Sclerosis.
    Gnanakkumaar P; Murugesan R; Ahmed SSSJ
    Sci Rep; 2019 Sep; 9(1):12732. PubMed ID: 31484947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resolution of inflammation during multiple sclerosis.
    Ruiz F; Vigne S; Pot C
    Semin Immunopathol; 2019 Nov; 41(6):711-726. PubMed ID: 31732775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple sclerosis and the spinal cord.
    Sheremata W; Tornes L
    Neurol Clin; 2013 Feb; 31(1):55-77. PubMed ID: 23186896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
    Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
    BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential spinal cord volume loss in primary progressive multiple sclerosis.
    Tsagkas C; Magon S; Gaetano L; Pezold S; Naegelin Y; Amann M; Stippich C; Cattin P; Wuerfel J; Bieri O; Sprenger T; Kappos L; Parmar K
    Mult Scler; 2019 Jun; 25(7):947-957. PubMed ID: 29781383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells.
    Guan H; Singh UP; Rao R; Mrelashvili D; Sen S; Hao H; Zumbrun EE; Singh NP; Nagarkatti PS; Nagarkatti M
    Immunology; 2016 Apr; 147(4):488-98. PubMed ID: 26780721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis.
    Takewaki D; Suda W; Sato W; Takayasu L; Kumar N; Kimura K; Kaga N; Mizuno T; Miyake S; Hattori M; Yamamura T
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22402-22412. PubMed ID: 32839304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease.
    McDonnell GV; McMillan SA; Douglas JP; Droogan AG; Hawkins SA
    J Neurol; 1999 Feb; 246(2):87-92. PubMed ID: 10195402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of MicroRNAs in Repair Processes in Multiple Sclerosis.
    Duffy CP; McCoy CE
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.
    Cristofanilli M; Gratch D; Pagano B; McDermott K; Huang J; Jian J; Bates D; Sadiq SA
    Mult Scler; 2017 Nov; 23(13):1707-1715. PubMed ID: 28273770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease-Modifying Treatment in Progressive Multiple Sclerosis.
    Ciotti JR; Cross AH
    Curr Treat Options Neurol; 2018 Apr; 20(5):12. PubMed ID: 29627873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.